NCT05894395 (MIPS) is a Phase 3 clinical trial of MMR booster vaccination (as M-M-R-VaxPro) in Mumps, sponsored by University of Zurich.

Who is sponsoring NCT05894395?

NCT05894395 is sponsored by University of Zurich.

What drugs are being tested in NCT05894395?

Interventions in NCT05894395: MMR booster vaccination (as M-M-R-VaxPro).

What condition does NCT05894395 study?

NCT05894395 studies Mumps, Measles, Rubella.

Is NCT05894395 still recruiting?

NCT05894395 is currently status unknown. Last updated 8 January 2024.

Last reviewed 2024-01-08 · How we verify

NCT05894395: MIPS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination

Status unknown Phase 3 Last updated 8 January 2024

What this trial tests

Phase 3 trial testing MMR booster vaccination (as M-M-R-VaxPro) in Mumps in 200 participants. Status unknown.

Timeline

1 December 2023

Primary endpoint
1 March 2025

1 September 2025

Quick facts

Lead sponsor	University of Zurich
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	200
Start date	1 December 2023
Primary completion	1 March 2025
Estimated completion	1 September 2025
Sites	2 locations across Switzerland

Drugs / interventions tested

MMR booster vaccination (as M-M-R-VaxPro) — full drug profile →

Conditions studied

Mumps — all drugs for Mumps →
Measles — all drugs for Measles →
Rubella — all drugs for Rubella →

Sponsor

University of Zurich

Who can join

Adults 18 to 49, any sex, with Mumps or Measles. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the immunity of persons fully vaccinated against measles, mumps and rubella and to examine the course of immunity after booster vaccination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Mumps

Currently open trials in the same condition.

NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting

Other University of Zurich trials

Trials by the same sponsor.

NCT07485699 — Soy Processing and Food Allergy · NA · not yet recruiting
NCT07516912 — Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland · not yet recruiting
NCT07473115 — Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustm · not yet recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT06481982 — Value of Advanced MRI Techniques in the Assessment of Endometriosis · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05894395 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Zurich
Last refreshed: 8 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05894395.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing